Clinical Dermatology Review

SYMPOSIUM ON ANDROGENIC ALOPECIA - REVIEW ARTICLE
Year
: 2022  |  Volume : 6  |  Issue : 2  |  Page : 75--79

Androgenetic alopecia – Medical management


Feroze Kaliyadan 
 Department of Dermatology, Sree Narayana Institute of Medical Sciences, Chalaka, Kerala, India

Correspondence Address:
Feroze Kaliyadan
Department of Dermatology, Sree Narayana Institute of Medical Sciences, Chalaka, Kerala
India

There are a number of options available for the medical management of androgenetic alopecia. The key questions for practitioners are what the available medications are and what is their efficacy? What are the possible side-effects of these options? Are there differences in response according to parameters like gender? Are combinations effective? What are the newer options available and what could the future hold? This narrative review attempts to answer these questions. The main focus is on the medical treatment options which have significant evidence as of now – minoxidil, 5 alfa-reductase inhibitors, low light laser therapy, and platelet-rich plasma.


How to cite this article:
Kaliyadan F. Androgenetic alopecia – Medical management.Clin Dermatol Rev 2022;6:75-79


How to cite this URL:
Kaliyadan F. Androgenetic alopecia – Medical management. Clin Dermatol Rev [serial online] 2022 [cited 2022 Sep 28 ];6:75-79
Available from: https://www.cdriadvlkn.org/article.asp?issn=2542-551X;year=2022;volume=6;issue=2;spage=75;epage=79;aulast=Kaliyadan;type=0